Effect of naringenin on the proliferative and metastatic capacities of human gastric cancer SGC-7901 cells

Miao JIA,Ameng SHI,Haitao? SHI,Yan WANG,Lei DONG,Xiaoyan GUO

DOI: https://doi.org/10.13753/j.issn.1007-6611.2016.03.006

2016-01-01

Abstract:Objective To investigate the effect of naringenin on the proliferative, adhesive, invasive and migratory capacities of human gastric cancer SGC-7901 cells. Methods SGC-7901 cells were treated with different concentrations of naringenin(0,100,200,400μmol/L) . Then the cell proliferative and adhesive capacities were measured by MTT assay, and the cell invasive and migratory capaci-ties were determined by Transwell assay. The mRNA and protein expression levels of metalloproteinase-2(MMP-2), MMP-9 and vas-cular endothelial growth factor( VEGF) in gastric cancer cells were detected by real-time PCR and Western blot. Results ①Naringe-nin had no effect on cell proliferation after 24 h treatment. However, the proliferative capacity of SGC-7901 cells was inhibited signifi-cantly when treated with naringenin for 48 h and 72 h(P<0. 05). ②The 200 and 400μmol/L naringenin significantly inhibited adhe-sive, invasive and migratory capacities of SGC-7901 cells(P<0. 05). The 100μmol/L naringenin only inhibited cell migratory capac-ity (P<0. 05), but had no effect on adhesive and invasive capacities. ③Naringenin effectively down-regulated the mRNA and protein expression of MMP-2 and MMP-9(P<0. 05), but had no effect on VEGF expression. Conclusion These findings suggest that narin-genin could inhibit the proliferative, adhesive, invasive and migratory capacities of SGC-7901 cells in vitro, which may be related to the inhibition of the expression of MMP-2 and MMP-9.